As of November 10, 2026, Editas Medicine, Inc. is a publicly traded company (Nasdaq: EDIT); its largest reported holder is TCG Crossover GP III, LLC, with 9.9% on Schedule 13G of June 3, 2026, then Commodore Capital (9.9%) (Schedule 13G, June 3, 2026).
Is this your company?
About to sign with, pay or invest in Editas Medicine, Inc.? See the free Snapshot first.
Free to see. No signup.
Is Editas Medicine, Inc. a real, registered company?
- Editas Medicine, Inc. files with the SEC under CIK 1650664 (its SEC filings).
- Its shares are listed under the ticker EDIT on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Cambridge, Massachusetts, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Editas Medicine, Inc. in our court records and SEC 8-K records (as of 2026-11-10).
- Leadership changes: the latest reported is Patrick Ellinor, Director (Form 8-K filed 2026-08-05). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names BlackRock (filed 2026-10-27).
Who are Editas Medicine, Inc.'s owners and officers?
Editas Medicine, Inc.: incorporated in Delaware; business address in Cambridge, Massachusetts; industry Biological Products, (No Diagnostic Substances) (Schedule 13G, 2026-10-27).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-10-27 | Blackrock, Inc. | 7.8% |
| Schedule 13G, 2026-08-14 | Adar1 Capital Management, LLC | 5.8% |
| Schedule 13G/A, 2026-07-29 | Blackrock, Inc. | 4.97% |
| Schedule 13G, 2026-06-03 | Ra Capital Management, L.P. | 5.8% |
| Schedule 13G, 2026-06-03 | Tcg Crossover Gp Iii, LLC | 9.9% |
| Schedule 13G, 2026-06-02 | Commodore Capital LP | 9.9% |
| Schedule 13G/A, 2026-03-26 | The Vanguard Group | 0% |
Questions about who owns Editas Medicine, Inc.
Who owns Editas Medicine, Inc.?
On this page, 5 holders' latest ownership filings report 5% or more of Editas Medicine, Inc.: Tcg Crossover Gp Iii, LLC (9.9%, Schedule 13G, filed 2026-06-03), Commodore Capital LP (9.9%, Schedule 13G, filed 2026-06-02), Blackrock, Inc. (7.8%, Schedule 13G, filed 2026-10-27), Adar1 Capital Management, LLC (5.8%, Schedule 13G, filed 2026-08-14) and Ra Capital Management, L.P. (5.8%, Schedule 13G, filed 2026-06-03).
Who are the largest shareholders of Editas Medicine, Inc.?
By the share each holder's latest filing reports, the largest holders of Editas Medicine, Inc. on this page are Tcg Crossover Gp Iii, LLC (9.9%), Commodore Capital LP (9.9%) and Blackrock, Inc. (7.8%).
When did Tcg Crossover Gp Iii, LLC buy into Editas Medicine, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Tcg Crossover Gp Iii, LLC on this page is the Schedule 13G, filed 2026-06-03, reporting 9.9%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 7 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Editas Medicine, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Editas Medicine, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Editas Medicine, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
14 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-08-05 | Patrick Ellinor | Director | appointed | 2026-08-06 |
Which insiders own Editas Medicine, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , the chief executive and a director: 286,756 shares (0.19% of shares outstanding) (Form 4, 2026-11-06).
- , the executive vice president and chief medical officer: 133,354 shares (0.09% of shares outstanding) (Form 4, 2024-12-05).
- , the chief financial officer and executive vice president: 112,720 shares (0.07% of shares outstanding) (Form 4, 2025-03-05).
- , the executive vice president and chief scientific officer: 78,193 shares (0.05% of shares outstanding) (Form 4, 2026-11-06).
- , the chief financial officer and senior vice president: 13,839 shares (0.01% of shares outstanding) (Form 4, 2026-09-04).
Shares outstanding: 154,339,748 as of 2026-11-06, from the company's latest SEC cover page.
How much has Editas Medicine, Inc. raised?
No fundraising or offering filing from Editas Medicine, Inc. is on file with us.
Keep reading
More on Editas Medicine, Inc. and the records around it.
Editas Medicine, Inc. elsewhere on the record
- 5%+ stake filings Oct 2026
- Leadership changes Aug 2026
Companies that share a holder
- TCG Crossover GP III, LLC also filed stake reports on 3 other companies: Research Alliance Corporation III (Aug 2026), Entera Bio Ltd. (Aug 2026), InflaRx N.V. (May 2026)
- ADAR1 Capital Management, LLC also filed stake reports on 29 other companies: InMed Pharmaceuticals, Inc. (Oct 2026), Tenax Therapeutics, Inc. (Sep 2026), Adagio Medical Holdings, Inc. (Aug 2026)
- Commodore Capital LP also filed stake reports on 40 other companies: Sagimet Biosciences Inc. (Oct 2026), Surrozen, Inc./DE (Oct 2026), JATT III Acquisition Corp (Sep 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/editas-medicine